Total Funding
25
72
Total FundingSeed raised
Growth Score 25 in past quarter
-1 pts
Heat Score 72 in past quarter
2 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
178592
Nuclease Probe Technologies is a platform for the early diagnosis of infectious diseases.
- James McNamara: Founder & Chief Executive Officer
About the Company
Nuclease Probe Technologies develops a phenotypic antibiotic susceptibility test that offers infection testing from blood samples and suggests the appropriate antibiotic for services. Early detection enables veterinarians and physicians to make informed treatment decisions faster and accomplish better outcomes for patients.
